Valter Croci

Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents

Monica Simeoni, Paolo Magni, Cristiano Cammia et al. · Cancer Research · 2004 · 499 citations · Full text

Medicine, Oncology, Pharmacology +16

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini et al. · Molecular Cancer Therapeutics · 2007 · 244 citations

Medicine, Oncology, Pharmacology +16

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 215 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

Chiara Soncini, Patrizia Carpinelli, Laura Gianellini et al. · Clinical Cancer Research · 2006 · 161 citations

Medicine, Oncology, Pharmacology +16

Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor

Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari et al. · Journal of Medicinal Chemistry · 2009 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17